Physician profile
Maykol Postigo Jasahui
NPI 1023305661
$321,868.90
in general payments reported to CMS, 2019-2025
13 companies · $190K in 2025
The $190K reported for 2025 was more than what 99% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,359 · 2020: $1,390 · 2021: $928 · 2022: $7,664 · 2023: $13K · 2024: $105K · 2025: $190K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $205K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $55K · Travel and Lodging: $30K · Food and Beverage: $17K · Honoraria: $750 · Consulting Fee: $730 · Gift: $72.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $204,875.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $55,000.00 |
| Travel and Lodging | $29,740.51 |
| Food and Beverage | $17,359.58 |
| Honoraria | $750.00 |
| Consulting Fee | $730.00 |
| Gift | $72.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $310,390.75 | 2019-2025 | Da Vinci Sp, Da Vinci Surgical System |
| Ethicon INC. | $2,260.79 | 2019-2022 | |
| Pinnacle Biologics, INC | $2,216.68 | 2022 | |
| Pulmonx Corporation | $1,864.76 | 2019-2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,300.00 | 2020 | |
| Olympus America INC. | $1,139.14 | 2021-2023 | Spiration Valve System |
| Veran Medical Technologies, INC. | $993.00 | 2019-2020 | |
| Cook Incorporated | $750.00 | 2024 | |
| Olympus Corporation | $730.00 | 2023 | |
| La Jolla Pharmaceutical Company | $120.00 | 2022 | |
| Boston Scientific Corporation | $43.85 | 2024 | Exalt Model D |
| Ambu INC. | $34.17 | 2023 | |
| Olympus Corporation of The Americas | $25.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maykol Postigo Jasahui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.